Industry Moves
Oct 23, 2026
•
6 min read
Three CD19 CAR-Ts report MS data, China drafts cell and gene therapy export limits, and Thermo Fisher's academic sales stay flat.
Oct 16, 2026
4 min read
Legend's in vivo CAR-T gets a US IND; Labcorp buys most of BioReference for $722M; Agilent buys Proscia
Oct 9, 2026
5 min read
CellCarta and Waters team up on flow CDx; ARUP builds a flow foundation model; Caribou steps back from allogeneic CAR-T
Oct 2, 2026
11 min read
CyTOF's new owner, NovoStation, PAMA cuts, and 36 verified flow jobs
